Home/Filings/4/0000950170-25-050410
4//SEC Filing

Sullivan Lynne Marie 4

Accession 0000950170-25-050410

CIK 0001463361other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 4:16 PM ET

Size

5.1 KB

Accession

0000950170-25-050410

Insider Transaction Report

Form 4
Period: 2025-04-02
Sullivan Lynne Marie
CFO & Head of Corp. Dev.
Transactions
  • Sale

    Common Stock, $0.0001 par value

    2025-04-02$1.03/sh21,867$22,52398,905 total
Footnotes (2)
  • [F1]Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
  • [F2]Includes Restricted Stock Units which vest over time measured from the grant date.

Documents

1 file

Issuer

Unity Biotechnology, Inc.

CIK 0001463361

Entity typeother

Related Parties

1
  • filerCIK 0001727640

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:16 PM ET
Size
5.1 KB